of the neuron, followed by Ca2+ Influx and transmitter release by exocytosis (Banks, 1967) . It could also lead indirectly to a rise in intracellular Ca2+, through mobilization of intracellular Ca2' stores (Baker and Crawford, 1975) through Ca2+ exchange for intracellular Na+ (Nakazato et al., 1978) or through inhibition of Ca2+ efflux (Pocock, 1983a, b) , which again would permit transmitter release by exocytosis. Raiteri and Levi (1978) have proposed that an increase in intracellular Na+ permits the nonvesicular efflux of transmitters by reversal of Na+-dependent plasma membrane carriers. Vizi et al. (1982) argue that inhibition of the Na,K-ATPase somehow directly results in transmitter release through unidentified membrane pathways, independent of changes in intracellular ion concentrations,
The fact that evidence has been presented in support of all of these models suggests that there is considerable heterogeneity in experimental preparations, such as in the properties of membrane pumps and channels. There are two molecular forms of the Na,KATPase, for example, which have different biochemical properties and different affinities for the cardiac glycosides (Sweadner, 1979) . The two forms can be expressed in different kinds of cells (Specht and Sweadner, 1984) and it is not known which form is expressed in preparations used previously to investigate the role of the Na,KATPase in transmitter release. In addition, the excision, slicing, or homogenization of a tissue may affect membrane leakiness, which could affect the steady-state metabolism of ions. It would be advantageous to study cells which have not been mechanically disturbed and in which the Na,K-ATPase has been identified.
In the experiments described here, the controversy has been addressed by examining the mechanism of ouabain-evoked release of [3H] norepinephrine from primary cultures of sympathetic neurons, which express the form of the Na,K-ATPase with a low affinity for cardiac glycosides (Sweadner, 1979) . Sympathetic neurons from neonatal rats can be maintained in primary cell culture in the virtual absence of other cell types, where they express the physiological, biochemical, and morphological characteristics of such neurons in the adult (Landis, 1976; O'Lague et al., 1978; Patterson, 1978) . The cultures release endogenous norepinephrine when stimulated electrically (Furshpan et al., 1976) . They also accumulate and store exogenous [3H] norepinephrine in a reserpine-sensitive pool and release it when treated with agents that are thought to elicit the exocytosis of synaptic vesicles, such as elevated extracellular K+ (Patterson et al., 1976) and black widow spider venom (Sweadner, 1983) . Such cultures are favorable for the study of the ionic basis of neurotransmitter release because the cells are intact, and because the uptake and efflux of ions from other cell types is eliminated.
Materials and Methods

Cel l cultures.
Primary cultures of postmltotic sympathetic neurons from the superior cervical ganglion of the newborn CD rat (Charles Rover Breeding Laboratories, Wilmington, MA) were prepared and maintained as described previously by Hawrot and Patterson (1979) , in medium containing 5.4 mM K+ and no conditioned medium. Cells were plated in 8-mm-diameter wells formed 2398 Sweadner Vol. 5, No. 9, Sept. 1985 by boring holes In 35mm Petrr dashes and sealing plastrc coverslips to the holes with wax. Cells (500 to lOOO/well) were plated on a substratum of dried collagen. and the cultures were marntained in bicarbonate-containing medium in the presence of nerve growth factor (the gift of A. Doupe, Harvard Medrcal School) for 3 to 6 weeks before use. Non-neuronal cells were eliminated during the first week after plating by treatment with arabinosylcytosine. [3H]norepinephrine, the release of tritrum was followed by changing the minimal salts solution every hour and measurrng the radioactivity released and that remaining in the cells at the end of the experiment.
Cultures were dissolved in 1% sodium dodecyl sulfate, and radioactivity was counted by liquid scintillation in Ultrafluor (National Dragnostics, Somerville, NJ). The data are displayed as the log of the total radioactivity remaining in the cells versus time; when release occurs as a simple exponentral, thts permrts expression of the rate of release as a half-time and corrects for the depletion of labeled intracellular stores. The absolute rates of release, both basal and stimulated, varied between platings but were very reproducible when cultures from the same plating were compared.
The experiments shown are representative results obtained wrth cultures from 14 dtfferent platings, and all experiments were repeated with cultures from at least two platrngs.
Release experiments were performed in mrnrmal salts solution instead of complete medium to avoid the fluctuations of pH attendant on using brcarbonate-containrng media. Control experiments performed in complete culture medium, including nerve growth factor, serum, and bicarbonate, gave the same results as experiments performed in minimal salts solution with glucose. Assay of Na,K-AT&se inhibit/on. Because the inhibition of the Na,KATPase by cardiac glycosides is slow, a continuous spectrophotometric assay was used to monitor the rate of hydrolysis of ATP so that equilibrium inhibition values could be measured.
ATP hydrolysis was coupled to the oxidation of nicotrnamide adenrne dinudleotrde (NADH) using pyruvate krnase and phosphoenolpyruvate to regenerate ATP and produce pyruvate, and lactate dehydrogenase to reduce pyruvate and oxidize NADH (Pullman et al., 1960) . The reaction was monitored at 340 nm rn a Perktn-Elmer Lambda' 3 spectrophotometer equipped with a thermoelectric cell holder set for 37°C. Hydrolysis in the absence of cardiac glycoside was linear with time provided that vanadium-free ATP was used (grade I ATP from Sigma Chemical Co., St. Louis, MO). ATP hydrolysis in the presence of cardiac glycosidedeclined slowly with time but reached a steady state within, at most, 20 to 30 min. Because of the limited quantities of sympathetic neurons available, membranes prepared from cultured rat brain non-neuronal cells (Sweadner, 1979) were substituted in these experiments. Previous work indicated that cultured sympathetic neurons and glia express the same form of the Na,K-ATPase by the cntena of cardiac glycosrde affinity and subunit electrophoretrc mobility (Sweadner, 1979) and more recent evidence has been obtained that they are antigenically cross-reactive as well (K. J. Sweadner and R. C. Gilkeson, manuscript in preparation).
The concentrations of NaCl and KCI were those used In the minimal salts solution. CaCI, was omitted, and choline chloride was added as appropriate.
ATP and MgC12 were both 3 mM, and the buffer was 30 mM HEPES/Trrs, pH 7.2. 
Results
Release elicited by inhibition of the Na, K-ATPase. The concentration of ouabain required to elicit [3H]norepinephrine release from sympathetic neurons was compared with that required to inhibit the Na,K-ATPase in vitro to estimate what fraction of pump activity must be inactivated for a measurable effect (Fig. 1) . The rate of release is expressed as the ratio of the half-time in untreated cells to the half-time in treated cells, to correct for plating-to-plating variations (up to 2-fold) in the basal rate of release. The activity of the enzyme was assayed in vitro in a reaction mixture that simulated the ionic conditions in the extracellular medium except for the presence of 3 mM ATP and 3 mM MgCI*, and the absence of 1.2 mM CaC&. Na+ and K+ concentrations typical of the extracellular environment were used instead of intracellular concentrations because the affinity of the ouabain-binding site, which faces the extracellular medium, is known to be affected by extracellular K+ (Schwartz et al., 1975) . Ouabain inhibited the Na,K-ATPase with a K. sof 3 X 1 Om5 M, whereas ouabain-or strophanthidin-elicited norepinephrine release had a much steeper concentration dependence. Accelerated release was seen only after a threshold was exceeded, when 80% or more of the Na,K-ATPase was inhibited.
Ouabain had no effect on norepinephrine release at concentrations less than 10T3 M, but at exactly 10m3 M it was observed in different replicate experiments to have three different kinds of effects: (7 ) no effect, (2) a rate of release intermediate between the control and that seen at 3 x 10m3 M ouabain, and (3) the effect illustrated in Figure 2 , where release occurred at the control rate for Inhibition of the Na,K-ATPase was measured in a membrane preparation obtarned from cultured rat brain glia, which express the same form of the Na,K-ATPase that is expressed by cultured rat sympathetic neurons. Ouabain-insensitive ATPase activity, which was approximately 50% of the total ATPase activity, was subtracted from the data shown. n , ouabain-sensitive ATPase activity. The relative rate of noreprnephrine release is expressed as the ratio of the half-time of release in the presence of ouabain (0) 2 hr and then abruptly increased to the rate seen in the presence of 3 X 10m3 M ouabain. Such a delayed effect of ouabain suggests that release is a result of cumulative changes inside the cells, rather than of an immediate consequence of inhibition of the pump.
In the experimental protocol used, the cultures are in contact with the newly released [3H]norepinephrine and are able to recapture some of it by high affinity uptake. To test the effect of recapture on the apparent rate of release, the experiments were repeated in the presence of the uptake inhibitor, desipramine (Iversen, 1975) . Figure  5 , A and B, shows that 10m5 M desipramine potentiates the apparent rate of release of [3H]norepinephrine elicited both by high K+ and by A23187. Desipramine had no detectable effect on the release of radioactivity from unstimulated cultures (not shown); such release has previously been shown to consist primarily of deaminated metabolites of norepinephrine, which are thought to diffuse passively from the cells (Patterson et al., 1976) . It is possible that ouabain might ellclt transmitter release at lower concentrations If the cells were electrically active and, thus, had
The desipramine-sensitive norepinephrine uptake from the extraincreased fluxes of either Na+ or Ca2'. Accordingly, the effect of cellular medium is known to be due to an Na+-dependent carrier, ouabain was examined in the presence of 54 mM K+ or of low levels and it should be possible to block it by reducing the concentration (1 Oe5 M) of A231 87. As in unstimulated cells, however, no consistent of extracellular Na+. The effect of reducing extracellular Na+ to 14
effect of ouabain could be demonstrated at concentrations of 10m3 mM, using choline as a substitute to maintain osmolarity and ionic M or lower (data not shown).
strength, was tested accordingly. Figure 6 , A and 6, shows that medium containing 14 mM Na+ had little or no effect on the release The high concentrations of ouabain required to elicit release suggest that the release may be in response to toxic conditions. Evidence that prolonged ouabain treatment is toxic comes from the observation that in some experiments it resulted in unmistakable deterioration of neurite structure (Fig. 3) . The neuronal cell bodies in the Cultures still looked similar to those in the controls, both by Nomarski and by phase contrast optics (not shown). When the cultures were fed complete culture medium and returned to the incubator, the cell bodies survived for more than a week, but there was little detectable recovery of normal axonal structure. Similar observations were made by Birks (1962) with electron microscopy of ouabain-treated superior cervical ganglia and neuromuscular junctions. However, with the cultured sympathetic neurons used here, the light microscopic appearance of the neuronal processes was always normal for the first several hours of ouabain treatment, and in fact structural deterioration was not seen consistenUy even after 6 hr in ouabain. There appear to be plating-to-plating differences in the ability of the cells to withstand the insult.
Norepinephrine release in response to conventional stimuli. To establish a basis for comparison with ouabaln, elevated extracellular K+ and the Ca*' ionophore A23187 were tested for their ability to 3. Light microscopic appearance of neuronal processes after extended treatment with ouabain. Neuronal processes were photographed at X 600 with Nomarski optics. A, Control; 6, after 6 hr in 10m5 M veratridine; C, after 6 hr in 10m3 M ouabain: D, after 6 hr in 3 x 10e3 M ouabain. 1972). K+ at 54 mM reduced the half-time of [3H]norepinephrine release from >360 min to 66 min in the presence of extracellular Ca2', but had very little effect when Ca2' was omitted from the solutions (Fig. 4A ). A23187 is a Ca" ionophore that has been observed to induce exocytotic release in a variety of cells (Pressman, 1976) . A single application of A23187 at 3 X 10V5 M was sufficient to sustain a rapid rate of norepinephrine release for several hours (Fig. 48) ; the drug readily penetrates the membrane and does not appear to wash out of the cells. The ionophore caused release even in the nominal absence of extracellular Ca2', suggesting that it may release Ca2+ from intracellular stores.
The dependence of norepinephrine release on exogenous Ca2' was tested by omitting Ca2' from the medium and replacing it with additional Mg2+. In intact tissues, Ca2' may leak from considerable intracellular stores into a restricted extracellular space, making it essential to use a Ca2' buffer to keep the extracellular concentration low, but in the dilute environment of the cultures the omission of Ca2' alone was sufficiently harsh to cause the cells to deteriorate after a period of hours. Spontaneous release of [3H]norepinephrine was unaltered for 4 to 6 hr ( Fig. 4A ; no Ca2' control), but after prolonged Ca2' deprivation, the cells released [3H]norepinephrine at an accelerated rate by an unknown mechanism. This may have been a consequence of cell death; neurons incubated without Ca2' for 24 hr deteriorated to the extent that they lost the ability to incorporate labeled L-leucine into protein (data not shown). of radioactivity from control cultures, but it potentiated the release from cells stimulated with 54 mM K+ or A23187 much as did desipramine. Ca*+ and Na+ dependence of the effect of ouabain. Ouabain and strophanthidin elicited rapid release of [3H]norepinephrine at concentrations of 3 X 10m3 M, and this release was not dependent upon the presence of Ca*+ In the extracellular medium (Fig. 7) . As a control for the leakage of Ca'+ from intracellular pools into the extracellular medium, ouabain was also tested in a Ca"-EGTA (ethyleneglycol his-(Saminoethyl ether)-N,N'-tetra-acetic acid) buffer with a final concentration of Ca*' of low7 M (Graf and Penniston, 1981) with the same result.
If the effect of inhibition of the Na,K-ATPase on transmitter release were a consequence of a net rise in the concentration of intracellular Na+, any experimental condition that reduces Na+ influx might be predicted to block the effect of ouabain. Experiments were thus performed in a medium containing only 14 mM Na+ with choline as a substitute, instead of 140 mM Na+. Ouabain did not elicit the release of [3H]norepinephrine in 14 mM Na+ (Fig. 8 ). This contrasts with the potentiating effect of similar ionic conditions on release elicited by high K+ or A23187 (Fig. 6, A and B) .
It is critical to know whether ouabain still inhibits the Na,K-ATPase in these altered ionic conditions; therefore, inhibition was measured in vitro in a reaction mixture containing 14 mM NaCl and 126 mM choline chloride and compared to the values obtained in the presence of 140 mM NaCI. As in the experiment shown in Figure 1 , CaC12 was omitted from the standard minimal salts solution, and the reaction mixture contained 3 mM ATP and 3 mM MgCl*. The result was that equilibrium half-maximal inhibition occurred at 3.1 x 1 Oe5 M ouabain in 140 mM NaCl and at 3.3 X lop5 M in 14 mM NaCI, 126 mM choline chloride. Since no transmitter release occurs with as much as 3 X 10m3 M ouabain in these ionic conditions, it would appear that inhibition of the Na,K-ATPase alone is not sufficient to cause the release.
Lowering extracellular Na+ would reduce the electrochemical driving force for Na+ entry and could have at least two consequences: it could reduce passive Na+ influx or it could reduce Na+:Ca*+ exchange. Tetrodotoxin at 10e5 M was found to delay the onset of ouabain-evoked
[3H]norepinephrine release by 2 to 3 hr (Fig. 9) . Although the voltage-sensitive Na+ gate is only one of several probable routes by which Na+ could enter the cell, it appears to make a significant contribution in the present experiments, supporting the hypothesis that net Na+ influx is the critical factor. Norepinephrine release via a carrier. The results of Figures 8 and 9 are most simply interpreted as consistent with the hypothesis that ouabain-elicited norepinephrine release is the consequence of a rise in the concentration of intracellular Na+. A simple model to explain release of [3H] norepinephrine that is independent of extracellular Ca*' and dependent on a rise in intracellular Na+ is that it could occur by efflux on the plasma membrane carrier instead of by exocytosis. To test this, desipramine was used to block the norepinephrine carrier while the Na,K-ATPase was inhibited with ouabain. Figure 10 shows that desipramine at 10e5 M completely blocked ouabain-elicited [3H]norepinephrine release. In other experiments it was determined that 10e6 M desipramine would block ouabainelicited [3H]norepinephrine release by 30 to 40%, whereas 10e7 M desipramine was without effect (data not shown).
Norepinephrine release in veratridine. Veratridine depolarizes neurons by opening the voltage-sensitive Na+ channel, and it has been used by other investigators to elicit transmitter release (reviewed in 
Minchin, 1980). It caused release of [3H]norepinephrine
from the cultured sympathetic neurons both in the presence and in the nominal absence of Ca2+ (Fig. 1 IA) . The effect of veratridine was blocked by 10d5 M tetrodotoxin, as expected from its specificity for the Na+ channel, and, in fact, tetrodotoxin could restore the resting rate of [3H]norepinephrine release after 2 to 3 hr of veratridinestimulated release (data not shown). In contrast to the release elicited by ouabain, however, the release elicited by veratridine was inhibited only approximately 50% by the carrier blocker desipramine (Fig.  1lB) .
Norepinephrine release in the absence of Na+. In Figure 6 it was shown that replacing all but 14 mM Na+ in the extracellular medium with choline had no effect on the resting rate of [3H]norepinephrine release. Complete removal of extracellular Na+ should have the effect of reversing the direction of the Na+ gradient across the membrane, and this would be predicted to drive the efflux of [3H] norepinephrine on the plasma membrane carrier even more effectively than the elevated intracellular Na+ concentrations produced by ouabain. As predicted, replacing all of the Na+ with choline elicited transmitter release (Fig. 12) . Substitution of Li+ or N-methylglucamine for Na+ had a similar result, except that release rate tended to be higher. This effect of Na+ depletion did not depend on the presence of Ca" in the extracellular medium, and it was neither enhanced nor inhibited consistently by treating the cells with ouabain, tetrodotoxin, or desipramine (not shown). The problem with complete substitution of the Na+ in the extracellular medium was that the resulting transmitter release rates were usually highly variable, even when triplicate cultures from the same platings were compared. The complete removal of Na+ appears to have complex consequences that we do not understand; thus, no confidence can be placed on an analysis of its mechanism.
Discussion
The experiments reported here suggest that inhibition of the Na,KATPase with ouabain results in [3H]norepinephrine release from intact sympathetic neurons by a mechanism quite different from conventional release by exocytosis. The effect of ouabain was not abolished in the nominal absence of Ca". It required conditions permissive for passive Na+ influx, and it was inhibited by a drug, desipramine, which blocks the Na+-dependent norepinephrine carrier (Iversen, 1975; Raiteri and Levi, 1978) . The simplest explanation is that ouabain permits intracellular Na+ levels to rise to the point that the carrier can run backwards: not necessarily at a rate comparable to its normal influx mode, but at a rate sufficient to allow a net efflux of the transmitter from the cell. Both high K+ and ouabain treatments are capable of producing nearly complete depletion of intracellular norepinephrine, which implies an equilibrium between the vesicular and cytoplasmic pools.
The mechanism of ouabain-elicited release. The most widely accepted model for transmitter release is that it occurs by exocytosis, dependent on an influx of extracellular Ca". Three laboratories have found ouabain-elicited catecholamine release from the adrenal medulla that is dependent on the presence of millimolar levels of exogenous Ca2' (Banks, 1967; Garcia et al., 1980; Wakade, 1981) and a similar observation has been made for norepinephrine release from sympathetic neurons innervating the vas deferens (Nakazato et al., 1978) . Other laboratories have found ouabain-evoked release that is only partially dependent on extracellular Ca2': in vascular smooth muscle (Lorenz, Powis, Vanhoutte, and Shephard, 1980; Palaty, 1981) and in skeletal muscle (Elmqvist and Feldman, 1965; Birks and Cohen, 1968; Baker and Crawford, 1975; Branisteanu et al., 1979; Vizi and Vyskocil, 1979) . A lack of dependence on extracellular Ca2' is not in itself sufficient evidence to argue that trasmitter release is nonvesicular, since vesicular release may result from the mobilization of intracellular Ca" stores or a reduction in Ca2' efflux. Catecholamine release from the adrenal medulla has been shown to be accompanied by the release of the chromaffin granule protein dopamine P-hydroxylase both when release was Ca2' dependent (Garcia et al., 1980) and when it was Ca'+ independent (Lastowecka and Trifaro, 1974; Pocock, 1983a) . In these cases, it is very likely that release was occurring by exocytosis. Unfortunately, we have been unable to detect release of dopamine P-hydroxylase from rat sympathetic neurons under any experimental condition; thus, we have no positive evidence for the absence of vesicular release in the present experiments (data not shown).
The results presented In this report do not rule out an effect of ouabain on Ca" influx, Na+:Ca'+ exchange, or the mobilization of Ca" from intracellular stores, but they can be most simply explained by a minrmal model which requires only that the concentration of intracellular Na+ rise and that transmitter leak from the cell as a result of the reversibility of an Na+-dependent membrane carrier. No dependence on extracellular Ca" could be demonstrated for the effect of ouabain, even when Ca"+ was buffered at lo-' M, which eliminates the need to invoke depolarization-induced activation of Ca'+ channels or an increased Ca'+ influx through Na+:Ca2+ exchange. Another plausible model would be that Ca2' efflux through Na':Ca2' exchange is decreased because of an increase in intracellular Na+, resulting in a higher intracellular level of Ca2'. This does not easily explain the effect of ouabain in causing release, however, because of the observed effect of reducing extracellular Na'. The presence of only 14 mM Na' in the extracellular medium would be expected to have a qualitatively similar effect on Ca2' efflux, and yet It blocks the effect of ouabain, rather than enhancing it. It is simpler to suppose that reducing the concentration of extracellular Na+ limits the passive rise in intracellular Na+ which follows the inhibition of the Na+ pump. The effect of tetrodotoxin in delaying ouabain-elicited release strengthens this argument, since tetrodotoxin should act only to reduce Na+ influx. An increase in the concentration of intracellular Na+ may ultimately result in the release of Ca'+ from mitochondria (Carafoli, 1982) but there is no known reason to postulate an effect of Ca" on the desipramine-sensitive catecholamine carrier.
The hypothesis that transmitters can sometimes be released from neurons by the reversal of plasma membrane carriers is gaining experimental support. Specific uptake blockers have been shown to prevent release of norepinephrine or dopamine (Blaszkowski and Bogdanski, 1972; Paton, 1973; Raiteri et al., 1977 Raiteri et al., , 1979 Lorenz et al., 1980; Lrang and Rutledge, 1982) . Amphetamine-induced release of norepinephrine is also apparently carrier mediated (Rutledge, 1978) . Amino acid transmitters may be released by an analogous mechanism (Levi and Raiteri, 1978; Schwartz, 1982; Yazulla and Kleinschmidt, 1983) . Schwartz (1982) proposed that carrier-mediated GABA release was activated by depolarization, which is reasonable if there is a net movement of charge on the carrier. In other cases, high intracellular Na+ or reversal of the Na+ gradient was thought to permit the reversal of membrane carriers.
In slices and synaptosomes from brain, ouabain-evoked release of acetylcholine (Vizi, 1972; Meyer and Cooper, 1981; Vyas and Marchbanks, 1981) and serotonin (Collard and Williams, 1981) is seen that is independent of extracellular Ca"'. It has been proposed by Vtzi (1972) that inhibition of the Na,K-ATPase is itself sufficient, independent of fluxes of either Na' or Ca'+, to cause transmitter release by such means as destabilizing the membrane or changing the intracellular pH. This model is clearly untenable here in view of the fact that the Na,K-ATPase can be inhibited by ouabain in the presence of reduced extracellular Na+, yet without any consequent release of transmitter. A dependence upon extracellular Na' (and by inference on Na' influx) has been demonstrated for the effect of ouabain on transmitter release in several laboratories (Birks, 1963; Birks and Cohen, 1968; Nakazato et al., 1978; Garcia et al., 1980; Pocock, 1983a) . A reduction in extracellular Na+ has also been observed to protect the neuron against the pathological changes in ultrastructure that are caused by prolonged poisoning with ouabain (Birks, 1962) . Some of the other apparent contradictions in the literature can be understood if one assumes that there are tissue-or cell-specific differences in the balance between exocytotic and carrier-mediated mechanisms. It is notable, for example, that no carrier-mediated release of catecholamines has been reported for the adrenal medulla, although that organ has been reported to have a high affinity uptake system for catecholamines analogous to the one in neurons (Kenigsberg and Trifaro, 1980; Role and Penman, 1983) . Even Na+ depletion IS thought to cause exocytotic release in the adrenal medulla (Lastowecka and Trifaro, 1974; Nrshimura et al., 1981) . Veratridine, which opens the voltage-sensitive Na+ gate, causes release from cultured sympathetic neurons that is independent of extracellular Ca"+ and that is at least partially inhibitable by desipramine. This contrasts with observations on rat brain synaptosomes, where the effect of veratridine was Ca'+ dependent and unaffected by desipramine (Mulder et al., 1975) and where it causes an increase in Ca'+ accumulation (Blaustein, 1975) . Since veratridine depolarizes the cell, allowing Ca*' to enter through voltage-sensitive channels as well as permrttrng drffusion-limited Na+ entry through the Nat gate, it is plausible that either Ca*+-dependent or Na+-dependent release mechanisms might predominate in different kinds of cells,
The lack of Na+ in the extracellular medium would be predicted to cause release by reversing the direction of the Na+ gradient, and yet desipramine had no consistent effect on norepinephrine release from sympathetic neurons in this condition. This may be due to a failure of the cells to maintain their integrity after prolonged Na+ depletion. In synaptosomes, however, desipramine and nomifensine have been found to cause partial inhibition of norepinephrine and dopamine release into medium lacking Na+ (Paton, 1973; Raiteri et al., 1977 Raiteri et al., , 1979 . Desipramine, like norepinephrine itself, may require extracellular Na+ for binding to the carrier (Lee and Snyder, 1981) with the consequence that it is ineffective in inhibiting outward transport into medium lacking Na+ at the concentrations used. Alternatively, desipramine may need to enter the cell by the Na+-dependent carrier before it can inhibit norepinephnne efflux.
Ouabain concentration and its physiological effects. The affinity of the Na,K-ATPase for ouabain can vary markedly depending on the species and on the concentration of K+ (Schwartz et al., 1975) and, in certain species, on which of two different forms of the Na,KATPase catalytic subunit is present. The two forms of the Na,KATPase have been separated, and are named LY, the kidney form, and a(+), the axolemma form, after their richest tissue sources (Sweadner, 1979) . In the rat, the kidney form, (Y, has an affinity for ouabain of 3 x 10m5 M as reported here, whereas the axolemma form, a(+), has an affinity of lo-' M (unpublished results).
It has been postulated that some of the physiological effects of ouabain on target tissues of the autonomic nervous system are a consequence of the release of neurotransmitter rather than of a direct effect of the drug on the target (reviewed by Gillis and Quest, 1980). A salient feature of the effect of ouabain on the heart is that it typically occurs at concentrations lower than those required to inhibit the cardiac Na,K-ATPase in vitro, a phenomenon that has resulted in much debate about the mechanism of ouabain inotropy. Lechat et al. (1983) have presented evidence that the inotropy seen at very low concentrations of ouabain in the guinea pig atrium may be due to the effects of autonomic transmitters. The low affinity form of the Na,K-ATPase is expressed in cultured sympathetic neurons of the rat (Sweadner, 1979) ; thus, it is not surprising that high concentrations of ouabain are required to elicit norepinephrine release here. However, the release of [3H]norepinephrine required a concentration of ouabain that is sufficient to cause nearly complete inhibition of even the low affinity Na,K-ATPase, which makes it unlikely that ouabain-elicited transmitter release can account for inotropy in the rat. The paradox could be explained if the sensitive cell, a sympathetic neuron or a cardiac cell, expressed the high affinity form of the catalytic subunit of the Na,K-ATPase in viva. Alternatively, the inotropic effect could result not from increased norepinephrine release, but from reduced norepinephrine reuptake; it would be of interest to contrast the ouabain concentration dependencies for the inhibition of norepinephrine uptake and the stimulation of norepinephrine release. The brain contains both forms of the Na,K-ATPase, whereas the forms expressed in most neurons innervating peripheral tissues is not known. It is possible that an apparent discrepancy in the sensitivities of different transmitters to release by ouabain is due to the use of a concentration of ouabain that is not sufficient to fully inhibit the low affinity form of the Na,K-ATPase. Raiteri et al. (1977) , for example, found the release of norepinephrine from rat brain synaptosomes to be very insensitive to 10m4 M ouabain, whereas Raiteri et al. (1979) found the release of dopamine to be very sensitive in the same species and under similar experimental conditions. These investigators presented evidence that both transmitters leave the cell by plasma membrane carriers. Unless there are fundamental differences In the properties of the norepinephrine and dopamine carriers, one would predict from these results that norepinephrine should be found in cells expressing the low affinity form of the Na,K-ATPase, and dopamine should be found in cells expressing the high affinity form. O'Fallon et al. (1981) found striking regional variations in the release of several transmitters from rat brain slices in response to 10m5 M ouabaln, a concentration that would be expected to inhibit only the high affinity form of the Na,K-ATPase; the use of a concentration of ouabain high enough to inhibit the lo'w affinity form as well might have given different results.
